Zymeworks is a global clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks’ mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases....See more
Headquarter Canada |
Year founded 2003 (21 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Regulatory Affairs Manager
Research Associate I, ADC Therapeutic Development
Managing Director
The company has a sophisticated ownership structure and may be part of a large corporate group
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
Regulatory Affairs Manager | hidden.item | hidden.item | hidden.item | |||
Research Associate I, ADC Therapeutic Development | hidden.item | hidden.item | hidden.item | |||
Managing Director | hidden.item | hidden.item | hidden.item |
Auditor: | KPMG LLP |
Share Capital - Ordinary shares: | hidden.item |
Sign up to view for free |
Company | Incorporation date | Country of Registration | Share capital | Local SIC |
---|---|---|---|---|
| 14 Feb 2023 | Singapore | USD 100,000 | 72106: RESEARCH AND EXPERIMENTAL DEVELOPMENT ON MEDICAL SCIENCE |